-

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Cardlytics, Inc. (CDLX) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Cardlytics, Inc. (“Cardlytics” or the “Company”) (NASDAQ: CDLX) investors concerning the Company’s possible violations of federal securities laws.

On August 7, 2024, Cardlytics released its second quarter 2024 financial results, missing consensus estimates due to “slower-than-anticipated billings growth coupled with higher consumer incentives.” Specifically, the Company stated that it had encountered “delivery issues” and “fast-paced changes to [its] technology platform” which led to “unpredictable delivery of the advertiser budgets.”

On this news, Cardlytics’ stock price fell $3.94, or 57.1%, to close at $2.96 per share on August 8, 2024, thereby injuring investors.

If you purchased Cardlytics securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847 or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

Law Offices of Howard G. Smith

NASDAQ:CDLX

Release Versions

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

More News From Law Offices of Howard G. Smith

Law Offices of Howard G. Smith Announces Investigation of Universe Pharmaceuticals INC. (UPC) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces it is investigating potential claims against the board of directors of Universe Pharmaceuticals INC. ("Universe Pharmaceuticals" or the "Company") (NASDAQ: UPC) concerning whether the board breached its fiduciary duties to shareholders. IF YOU ARE A UNIVERSE PHARMACEUTICALS INC. (UPC) SHAREHOLDER, CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE. Contact Us To Participate or Learn More: If you still hold Universe...

Law Offices of Howard G. Smith Encourages The Chemours Company (CC) Shareholders To Inquire About Securities Fraud Class Action

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased The Chemours Company (“Chemours” or the “Company”) (NYSE: CC) common stock between February 20, 2026 and August 4, 2026, inclusive (the “Class Period”). Chemours investors have until December 7, 2026 to file a lead plaintiff motion.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CHEMOURS COMPANY (CC), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO...

Law Offices of Howard G. Smith Encourages The Ensign Group, Inc. (ENSG) Shareholders To Inquire About Securities Fraud Class Action

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased The Ensign Group, Inc. (“Ensign” or the “Company”) (NASDAQ: ENSG) common stock between February 10, 2022 and June 18, 2026, inclusive (the “Class Period”). Ensign investors have until December 7, 2026 to file a lead plaintiff motion.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN THE ENSIGN GROUP, INC. (ENSG), CONTACT THE LAW OFFICES OF HOWARD G....
Back to Newsroom